Matchpoint Therapeutics Inc

Matchpoint Therapeutics Inc. develops biotechnology solutions for immune diseases and serious illnesses. The company uses its proprietary ACE platform, combining chemoproteomics, machine learning, and compound library evolution to discover and develop oral covalent inhibitors for inflammatory and autoimmune conditions. Matchpoint Therapeutics Inc serves patients in the US.